DaVita (STU:TRL) Cyclically Adjusted PS Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TRL DaVita Inc STU:TRL
86 GF Score
Price €198.90
GF Value €152.65
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita  (STU:TRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DaVita Cyclically Adjusted PS Ratio Related Terms


DaVita Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for DaVita's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Cyclically Adjusted PS Ratio Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 0.87 1.10 1.43 0.95

DaVita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.16 0.95 1.24 0.00

STU:TRL vs EHC, THC, ENSG: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.


STU:TRL
86GF Score
DaVita Inc STU:TRL
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, DaVita's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=46.677/333.9520*333.9520
=46.677

Current CPI (Jun. 2026) = 333.9520.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 16.061 241.428 22.216
201612 13.007 241.432 17.991
201703 12.598 243.801 17.256
201706 12.385 244.955 16.885
201709 12.120 246.819 16.399
201712 12.714 246.524 17.223
201803 12.709 249.554 17.007
201806 14.194 251.989 18.811
201809 14.589 252.439 19.300
201812 14.901 251.233 19.807
201903 14.556 254.202 19.123
201906 15.083 256.143 19.665
201909 17.429 256.759 22.669
201912 20.015 256.974 26.011
202003 20.263 258.115 26.216
202006 20.613 257.797 26.702
202009 20.028 260.280 25.697
202012 20.639 260.474 26.461
202103 20.806 264.877 26.232
202106 21.725 271.696 26.703
202109 22.739 274.310 27.683
202112 24.862 278.802 29.780
202203 25.455 287.504 29.567
202206 28.318 296.311 31.915
202209 31.933 296.808 35.929
202212 29.970 296.797 33.722
202303 29.012 301.836 32.099
202306 29.645 305.109 32.447
202309 31.100 307.789 33.744
202312 31.092 306.746 33.850
202403 31.198 312.332 33.358
202406 33.282 314.175 35.377
202409 34.274 315.301 36.301
202412 37.533 315.605 39.715
202503 36.687 319.799 38.311
202506 37.875 322.561 39.213
202509 39.502 324.800 40.615
202512 43.409 324.054 44.735
202603 42.896 330.213 43.382
202606 46.677 333.952 46.677

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is DaVita (STU:TRL) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €198.90 is trading 30.3% above its estimated GF Value™ of €152.65. GuruFocus considers DaVita to be Modestly Overvalued.

Key valuation signals for STU:TRL:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €152.65 vs. price of €198.90 (30.3% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the STU:TRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
86GF Score

Get the complete analysis for STU:TRL

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€198.90
Price
€152.65
GF Value